USANA Health Sciences Inc（USNA）資訊與事件USNAUSANA Health Sciences Inc

Nasdaq Rebounds as Tech Stocks Surge

A broad-based rebound in the Tech space, particularly among the "pro-AI" semiconductor and computer hardware stocks, helped Nasdaq Composite to bounce off its 200-day moving average after three sessions of outsized losses.  Tech and the "AI-buildout adjacent" Industrials - where, notably, Eatonsaw sharp post-earnings gains of 7% on Tuesday - were also the best performing sectors in the S&P 500.  In contrast, the Consumer Staples sector, which had been the best market space since the AI trade turned sour in the first week of October, was the worst sector for the benchmark on Tuesday.  After hitting their highest levels since May overnight, names like Walmartand Costcosold off by over 2%.In the opening hour of the evening session, Nasdaq 100 and S&P e-Minis contracts had initially sustained the momentum of the upward inflection on Tuesday thanks to strong post-earnings gains from Tech heavyweights AMDand Super Micro.  Early midterm election results are hinting at a strong showing for the Democrat party however, and its potentially more adverse position toward the data center buildout is now weighing on sentiment.  S&Ps were down 0.3% and Nasdaq 100 contract was off by 0.6%.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Arista Networksup 11.9%Duolingoup 11.7%Flywireup 11.2%Super Micro Computerup 9.9%Ousterup 7.2%Blockup 6.8%Advanced Micro Devicesup 6.7%Transcatup 6.1%Hecla Miningup 6.0%Prudential Financialup 1.2%DOWN AFTER EARNINGS -Amdocs Limiteddown 43.8%Skyworks Solutionsdown 16.3%USANA Health Sciencesdown 10.3%Avis Budget Groupdown 6.5%Red Rock Resortsdown 6.4%Revolve Groupdown 6.1%Marqetadown 5.2%Toastdown 3.4%Amgendown 1.6%Booking Holdingsdown 1.0%

USANA Q2 Revenue $223M, Below Expectations

Reports Q2 revenue $223M vs. $236M last year. "Our consolidated second quarter results reflect mixed performance as the Core Nutritional business delivered results generally in line with our expectations, while our ventures businesses performed below expectations," said Kevin Guest, Chairman and Chief Executive Officer. "Specifically, Hiya continued to experience a challenging digital marketing environment, which pressured topline performance, subscriber growth, and margins. Additionally, Rise Wellness experienced a packaging-related disruption that impacted its commercial execution during the quarter. While we believe that these challenges for Hiya and Rise are temporary, and both companies remain well positioned to execute their growth strategies, we now expect net sales for these businesses during the full year to be below our prior expectations and are updating our outlook accordingly. We remain confident in USANA's strategic transformation from a single-channel direct sales business into a diversified, omnichannel health and wellness company built on consumer acquisition and loyalty. We are continuing to evolve our Brand Partner incentive plan, accelerate product innovation, and modernize our technology infrastructure. We remain confident that these initiatives will lead to long-term sustainable growth. Hiya's talented management team continues to embrace the opportunity to leverage their brand across additional channels to reach a broader consumer base, while continuing to build on strong performance at a major national retailer, early-stage international expansion, and encouraging momentum in additional e-commerce channels. Rise Wellness' high growth protein beverage brand, Protein Pop, is just a year old, and continues to attract new retailers, expand its presence with existing retailers and create the foundation for an exciting and expanded product pipeline. We recognize this progress will not always be linear quarter to quarter, and as we manage the business with that expectation in mind, our focus remains on building long-term loyalty from the consumers and Brand Partners who depend on our brands."

Lowers Revenue Outlook to $910M

Lowers revenue view to $910M from $925M-$1B. Lowers adjusted EBITDA view to $87M from $101M-$109M.